Skip to content
Axe Capital logo Axe Capital Trading News

Should you Avoid Constellation Brands Stock, Even at a 52-Week Low?

2026-09-06 09:25 John Ballard The Motley Fool Positive Axe Cap view: Selective RatesEquitiesEarningsCapital ReturnsConsumerRetail STZ

Axe Cap view

Is Constellation Brands Worth It at This Low?

Constellation Brands has fallen sharply, but its valuation and dividend yield invite a closer look.

Constellation Brands (STZ) has taken a beating, dropping 53% amid weak consumer spending and softer demand for discretionary items like craft beer. Yet, this stock now trades at just 11 times expected earnings, a rare bargain for a name owning powerful brands like Modelo and Corona. Modelo's recent market share gains show the strength behind the labels, and a steady free cash flow nearing $1.83B gives it financial muscle. The 3.2% dividend yield is attractive in a low-yield world, especially after the haul in price. For South African investors, there's no direct JSE stock match, so keep an eye on USD/ZAR. A stronger rand would diminish gains when converted back, while a weaker rand could sweeten returns. But tread carefully—if consumer sentiment deteriorates further, or inflation pushes input costs relentlessly higher, this stock could disappoint before it bounces back. this is just our opinion and not financial advice

How I would invest

We would watch Constellation Brands for an entry around current levels, especially if the rand remains stable or weak; for now, avoid jumping in heavily but trim some other consumer names to accumulate selectively.

What I would watch
  • STZ
  • USD/ZAR
What could go wrong
  • Further decline in US consumer spending
  • Stronger ZAR reducing rand-based gains
How strongly I feel

6/10

Constellation Brands stock has dropped 53% to around $128, reflecting weak consumer spending and soft demand. However, at 11x forward earnings with strong brand power (Modelo and Corona remain market leaders), exclusive distribution rights, and a historically high 3.2% dividend yield, the stock appears undervalued with much of the bad news already priced in.

Our take is based on reporting first published by The Motley Fool.

Read the original story